First CTA authorization marks nChroma’s transition to a clinical-stage company; first patient dosing in Phase 1/2 trial planned for early 2026 Preclinical studies demonstrated CRMA-1001 delivers ...
The data demonstrated that finite-duration 24-week AHB-137 monotherapy achieved a 30% functional cure rate at Week 72 (EOF) in patients with baseline HBsAg 100--1,000 IU/mL. This finding strengthens ...
ScienceAlert on MSN
DNA From Beethoven's Hair Reveals a Surprise 200 Years Later
On a stormy Monday in March, 1827, the German composer Ludwig van Beethoven passed away after a protracted illness.
Background Withdrawal of prolonged nucleos(t)ide analogue (NA) treatment results in hepatitis B surface antigen (HBsAg) loss in some subjects with chronic hepatitis B (CHB), potentially revealing ...
Researchers found that both how often and how much someone drinks significantly shape their cancer risk, even at moderate ...
STOCKHOLM, Sweden, December 11, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces that its portfolio company SVF Vaccines has presented new preclinical data on its immunotherapy ...
A wreath of ten crAssviruses – hugely abundant viruses that infect gut bacteria and are part of your normal, healthy ...
Memorial Sloan Kettering Cancer Center researchers continued to make strides against cancer in 2025. Learn about some of ...
Viruses are typically described as tiny, perfectly geometric shells that pack genetic material with mathematical precision, ...
"He is swayed by data, the scientific method, and clinical experience" but a mob got Kirk Milhoan fired because he leads a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback